Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria

Cancer Research

Volumn 58, Issue 24, 1998, Pages 5777-5786

  Miccoli, Laurent ^a   Beurdeley Thomas, Arnaud ^a   De Pinieux, Gonzague ^a   Sureau, Franck ^b   Oudard, Stéphane ^a   Dutrillaux, Bernard ^a   Poupon, Marie France ^a  

^a INSTITUT CURIE   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; GLUCOSE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; HEXOKINASE; HYPERICIN; LIPOCORTIN 5; MESSENGER RNA; OXYGEN; THYMIDINE;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL PH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENERGY METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOMA CELL; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRION; OXIDATIVE STRESS; PHOTOACTIVATION; PRIORITY JOURNAL;

APOPTOSIS; ENERGY METABOLISM; ENZYME INHIBITORS; GLIOMA; HEXOKINASE; HUMANS; HYDROGEN-ION CONCENTRATION; LIGHT; MITOCHONDRIA; PERYLENE; RADIATION-SENSITIZING AGENTS; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0032535579     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dougherty, T. J. Photodynamic therapy. Photochem. Photobiol., 58: 895-900, 1993.
2. Walther, M. M., Delaney, T. F., Smith, P. D., Friauf, W. S., Thomas, G. F., Shawker, T. H., Vargas, M. P., Choyke, P. L., Linehan, W. M., Abraham, E. H., Okunieff, P. G., and Glatstein, E. Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder. Urology, 50: 199-206, 1997.
3. Reynolds, T. Photodynamic therapy expands its horizons. J. Natl. Cancer Inst., 89: 112-114, 1997.
4. Kelley, E. E., Buettner, G. R., and Burns, C. P. Production of lipid-derived free radicals in L1210 murine leukemia cells is an early oxidative event in the photodynamic action of photophrin. Photochem. Photobiol., 65: 576-580, 1997.
5. Dougherty, T. J., Gomer, C. J., and Weishaupt, K. R. Energetics and efficiency of photoinactivation of murine tumor cells containing hematoporphyrin. Cancer Res., 36: 2330-2333, 1976.
6. Diwu, Z., and Lown, J. W. Phototherapeutic potential of alternative photosensitizers to porphyrins. Pharmacol. Ther., 63: 1-35, 1994.
7. Duran, N., and Song, P. S. Hypericin and its photodynamic action. Photochem. Photobiol., 43: 677-680, 1986.
8. Giese, A. C. Hypericism. Photochem. Photobiol. Rev., 5. 229-255, 1980.
9. Muruelo, D., Lavie, G., and Lavie, D. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective dose: aromatic polycyclic diones hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA, 85: 5230-5234, 1988.
10. Thomas, C., MacGill, R. S., Miller, G. C., and Pardini, R. S. Photoactivation of hypericin generates singlet oxygen in mitochondria and inhibits succinoxidase. Photochem. Photobiol., 55: 47-53, 1992.
11. Miskovsky, P., Sureau, F., Chinsky, L., and Turpin, P. Y. Subcellular distribution of hypericin in human cancer cells. Photochem. Photobiol., 62: 546-549, 1995.
12. Utsumi, T., Okuma, M., Kanno, T., Takehara, Y., Yoshioka, T., Fujita, Y., Horton, A. A., and Utsumi, K. Effect of the antiretroviral agent hypericin on rat liver mitochondria. Biochem. Pharmacol., 50: 655-662, 1995.
13. Utsumi, T., Okuma, M., Utsumi, T., Kanno, T., Yasuda, T., Kobuchi, H., Horton, A. A., and Utsumi, K. Light-dependent inhibition of protein kinase C and superoxide generation of neutrophils by hypericin, an antiretroviral agent. Arch. Biochem. Biophys., 316: 493-497, 1995.
14. de Witte, P., Agostinis, P., Van Lint, J., Merlevede, W., and Vandenheede, J. R. Inhibition of epidermal growth factor receptor tyrosine kinase activity by hypericin. Biochem. Pharmacol., 46: 1929-1936, 1993.
15. Vandenbogaerde, A. L., Delaey, E. M., Vantieghem. A. M., Himpens, B. E., Merlevede, W. J., and de Witte, P. A. Cytotoxicity and antiproliferative effect of hypericin and derivatives after photosensitization. J. Photochem Photobiol 67: 119-125, 1998.
16. He, J., Whitacre, C. M., Xue, L. Y., Berger, N. A., and Oleinick, N. L. Protease activation and cleavage of poly(ADP-ribose) polymerise: an integral part of apoptosis in response to photodynamic treatment. Cancer Res., 58: 940-946, 1998.
17. Granville, D. J., Jiang, H., An, M. T., Levy, J. G., McManus, B. M., and Hunt, D. W. Overexpression of Bcl-X(L) prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA. FEBS Lett., 422: 151-154, 1998.
18. Hamilton, H. B., Hinton, D. R., Law, R. E., Gopalakrishna, R., Su, Y. Z., Chen, Z. H., Weiss, M. H., and Couldwell, W. T. Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: potential therapeutic application. J. Neurosurg., 85: 329-334, 1996.
19. Weller, M., Trepel, M., Grimmel, C., Schabet, M., Bremen, D., Krajewski, S., and Reed, J. C. Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. Neurol. Res., 19: 459-470, 1997.
20. Vandenbogaerde, A. L., Geboes, K. R., Cuveele, J. F., Agostinis, P. M., Merlevede, W. J., and De Witte, P. A. Antitumour activity of photosensitized hypericin on A431 cell xenografts. Anticancer Res., 16: 1619-1625, 1996.